Andrew J Murtha

7PUBLICATIONS
74CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Jun 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|Feb 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.

Nicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts

|May 04, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.

Nicolette M Fonseca, Kim Van der Eecken, Cameron Herberts

|Jan 08, 2021
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.

Evan Warner, Cameron Herberts, Simon Fu

Pageof 2

Frequent Collaborators

6 joint publications

Alexander W Wyatt

4 joint publications

Gang Wang

4 joint publications

Cameron Herberts

3 joint publications

Bernhard J Eigl